We have a large contigency of clinics and ambulatory practices within our systtem and have (relatively) recently acquired many more. As part of our new medication safety program, we are developing an ambulatory specific medication safety program.

I am wondering if anyone has done this sucessfully - and would be willing to share the structure, frequency and charter ?

our safety events are very low volume, even though medications are given in the clinics. May experience or sharing would be appreciated !

Hello, our institution typically uses the premixed bag for diltiazem, however in this instance, it has been ordered but will not be received for a few weeks.

Our plan is to make the minibag+vial for nurses to activate at bedside.

There are safety concerns around this because the diltiazem is a liquid formulation.

Have you had any experience with this concern? If so, I would appreciate if you could share how you mitigated it.

Hello all.

Our nurses have expressed a concern with an EPIC workflow related to "autoheld" medications.

For those of you who use EPIC at your organization, what are the expectations for your physicians and nurses on addressing medications that were "autoheld" during a procedure & then resumed?

Does anyone know anything about a shortage of 70/30 Insulin, either for the in-hospital setting or for prescriptions outpatient? Thank you.

I was wondering if anyone has specific guidance/requirements/limits to the administration of norepinephrine via peripheral line?i.e up to a defined max rate or time period... If so would you mind sharing?

Interested in any staff educational materials that you or your healthcare facility has created and is willing to share on One Piece Flow/Single Piece Flow (sometimes also called continuous flow), versus batching. I am particularly interested in any pharmacy-centric examples highlighting medication preparation prior to dispensing.

Any information you can share is greatly appreciated!
Thank you-

We are currently evaluating our IV guidelines, specifically regarding the primary sources for determining beyond-use dating (BUD) for IV stability—whether to rely on manufacturing inserts or primary literature. We are seeking additional information on how other facilities establish BUD when the manufacturer's insert does not provide sufficient details.

Recognizing that this could vary by state, do you have any restrictions on what an LPN or paramedic can administer in comparison to RNs?

Thank you,
Stacie Ethington MSN, RN
Nebraska Medicine

It appears most brands of albumin no longer require special tubing. Do most facilities just use regular/standard IV tubing?

Would anyone be willing to share their protect from light policy? If you do not have a policy can you comment on how you delineate between protect from light for storage of medications vs those needing protect from light from mixing to administration?
Thanks all!